<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ROA</journal-id>
<journal-id journal-id-type="hwp">sproa</journal-id>
<journal-title>Research on Aging</journal-title>
<issn pub-type="ppub">0164-0275</issn>
<issn pub-type="epub">1552-7573</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0164027511415245</article-id>
<article-id pub-id-type="publisher-id">10.1177_0164027511415245</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Comparison of Inflammatory, Metabolic, and Anthropometric Parameters in Elderly Women With and Without Insulin Resistance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Silva</surname><given-names>Alessandro O.</given-names></name>
<xref ref-type="aff" rid="aff1-0164027511415245">1</xref>
<xref ref-type="aff" rid="aff2-0164027511415245">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Oliveira</surname><given-names>Hildeamo B.</given-names></name>
<xref ref-type="aff" rid="aff2-0164027511415245">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tavares</surname><given-names>Adriano B.</given-names></name>
<xref ref-type="aff" rid="aff1-0164027511415245">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Funghetto</surname><given-names>Silvana S.</given-names></name>
<xref ref-type="aff" rid="aff3-0164027511415245">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Prestes</surname><given-names>Jonato</given-names></name>
<xref ref-type="aff" rid="aff1-0164027511415245">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Karnikowski</surname><given-names>Margô G. O.</given-names></name>
<xref ref-type="aff" rid="aff1-0164027511415245">1</xref>
<xref ref-type="aff" rid="aff3-0164027511415245">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0164027511415245"><label>1</label>Catholic University of Brasilia, Graduation Program in Gerontology and Graduation Program in Physical Education and Health, Taguatinga, Brazil</aff>
<aff id="aff2-0164027511415245"><label>2</label>UNIEURO University Center, Physical Education Course, Brazil</aff>
<aff id="aff3-0164027511415245"><label>3</label>University of Brasilia (UnB), Brazil</aff>
<author-notes>
<corresp id="corresp1-0164027511415245">Margô G. O. Karnikowski, PhD, University of Brasilia, UnB Ceilândia Campus. QNN, 14 AE, Guariroba, Ceilândia Sul, 72220-140, Brasilia, DF, Brazil. Email: <email>margo@unb.br</email></corresp>
<fn fn-type="other" id="bio1-0164027511415245">
<p>Alessandro O. Silva is a PhD student from the graduate program in Physical Education and Health at the Catholic University of Brasilia.</p></fn>
<fn fn-type="other" id="bio2-0164027511415245">
<p>Hildeamo B. Oliveira is a professor of Physical Education at the Unieuro University Center.</p></fn>
<fn fn-type="other" id="bio3-0164027511415245">
<p>Adriano B. Tavares is an associate research professor of the graduate program in Gerontology at the Catholic University of Brasilia.</p></fn>
<fn fn-type="other" id="bio4-0164027511415245">
<p>Silvana S. Funghetto is a PhD student at the University of Brasilia.</p></fn>
<fn fn-type="other" id="bio5-0164027511415245">
<p>Jonato Prestes is an associate research professor of the graduate program in Physical Education and Health at the Catholic University of Brasilia.</p></fn>
<fn fn-type="other" id="bio6-0164027511415245">
<p>Margô G. O. Karnikowski is an associate research professor of the Faculty of Ceilandia at the University of Brasilia.</p></fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>34</volume>
<issue>3</issue>
<fpage>261</fpage>
<lpage>274</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The objective of the present study was to investigate the relationship between inflammatory, metabolic, and anthropometrical parameters of elderly women with insulin resistance (IR) and without insulin resistance (WIR). One hundred and seventy-two elderly women aged 67.5 (± 5 years) were submitted to anthropometrical analysis, by dual energy X-ray absorptiometry, and biochemistry tests such as lipidogram, fasting blood glucose, glycosylated hemoglobin, insulin, C-reactive protein, Interleukin-6, tumor necrosis factor-alpha, and Interferon-gamma. Body mass index, waist circumference, waist-to-hip ratio, body fat mass, triglycerides, very low density lipoprotein, fasting glucose, and insulin were significantly higher, while lean body mass was lower (<italic>p</italic> &lt; 0.05), in elderly with IR as compared to WIR. There was no significant difference between groups in the inflammatory parameters. Elderly women with IR present increased anthropometrical and metabolic parameters that predispose them to several chronic nontransmissible diseases. Additional inflammatory parameters should be used in elderly women to define an optimal relationship with insulin resistance in clinical practice.</p>
</abstract>
<kwd-group>
<kwd>aging</kwd>
<kwd>inflammation</kwd>
<kwd>blood biomarkers</kwd>
<kwd>insulin resistance</kwd>
<kwd>metabolic parameters</kwd>
<kwd>anthropometric parameters</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The demographic and epidemiologic transition is a world wild phenomenon characterized by the increased number of elderly people and a modification in the morbi-mortality profile of the population (<xref ref-type="bibr" rid="bibr5-0164027511415245">Camarano, 2007</xref>). In Brazil, the gradual increase in number of individuals aged 60 years or older and the elevated prevalence of chronic nontransmissible diseases (CNTD) indicate that the country is under an aging process of its population (<xref ref-type="bibr" rid="bibr26-0164027511415245">Oliveira, 2008</xref>). Among the most detachable CNTD are hypertension, diabetes, obesity, dyslipidemias, cardiovascular disease, and cancer, which are associated with inflammatory, metabolic, anthropometric, and body composition alterations (<xref ref-type="bibr" rid="bibr9-0164027511415245">Ford, 1999</xref>; <xref ref-type="bibr" rid="bibr10-0164027511415245">Forsey et al., 2003</xref>; <xref ref-type="bibr" rid="bibr18-0164027511415245">Lakka, Lakka, Salonen, Kaplan, &amp; Salonen, 2001</xref>).</p>
<p>There is an association between C reactive protein (CRP) elevated levels and the risk of development of coronary and cardiovascular disease in diabetic, hypertensive, and obesity profile individuals (<xref ref-type="bibr" rid="bibr9-0164027511415245">Ford, 1999</xref>). The involvement of adipose tissue with CNTD seems to be related with the elevated production of adipokines, such as Interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) (<xref ref-type="bibr" rid="bibr8-0164027511415245">Fonseca-Alaniz, Takada, Alonse-Vale, &amp; Lima, 2006</xref>).</p>
<sec id="section1-0164027511415245">
<title>Description of Problem</title>
<p>Body fat excess, especially in visceral compartments, is considered an indicator of inflammatory and metabolic disturbances, including hypertrigiceridemia, elevated levels of low density lipoprotein (LDL), and insulin resistance (IR) (<xref ref-type="bibr" rid="bibr18-0164027511415245">Lakka et al., 2001</xref>). The correlation between obesity and insulin resistance that is associated with type 2 diabetes can be shown by the IR syndrome that consists of hyperinsulinemia, dyslipidemia, obesity, and hypertension (<xref ref-type="bibr" rid="bibr22-0164027511415245">McLellan, Barbalho, Cattalini, &amp; Lerario, 2007</xref>).</p>
<p>IR is a clinical condition characterized by a blunted insulin-stimulated glucose transport capacity (<xref ref-type="bibr" rid="bibr29-0164027511415245">Stephens et al., 2004</xref>). In obesity and type 2 diabetes, IR can be related to alterations in the insulin-transduction signaling pathway, with a decreased number and kinase activity of the insulin receptor, and reduced levels and phosphorylation of SRI-1, SRI-2, and PI3-kinase activity, which are important intracellular molecules associated with glucose transport (<xref ref-type="bibr" rid="bibr11-0164027511415245">Franceschi et al., 2000</xref>).</p>
<p>Furthermore, the interaction between IR, inflammation, and obesity is a strong physiopathological hypothesis for the metabolic syndrome (MS) (<xref ref-type="bibr" rid="bibr22-0164027511415245">McLellan et al., 2007</xref>). MS represents a conjunct of factors predisposing to cardiovascular disease, usually related with central adipose tissue deposits and IR (<xref ref-type="bibr" rid="bibr2-0164027511415245">Bergman et al., 2001</xref>). Visceral fat plays an important role in the metabolic disturbance involved in dyslipidemias, IR, hyperglycemia, and a pro-inflammatory state (<xref ref-type="bibr" rid="bibr2-0164027511415245">Bergman et al., 2001</xref>).</p>
<p>Research focused on clarifying the association of metabolic indicators, inflammatory biomarkers, and obesity with IR would assist in the prevention and treatment of CNTD risk factors in elderly individuals. Thus, the aim of the present study was to investigate the relationship between inflammatory, metabolic, and anthropometric parameters in elderly women with and without insulin resistance. Our initial hypothesis was that elderly women with insulin resistance would present higher levels of inflammatory parameters as compared with those without insulin resistance.</p>
</sec>
<sec id="section2-0164027511415245" sec-type="methods">
<title>Method</title>
<p>This study was characterized by a transversal and analytic intervention with elderly women living in a community of the Federal District, administered over 2005, 2006, and 2007 in the ambulatory of the University Hospital of Catholic University of Brasilia (HUCB). The inclusion criteria were as follows: age ≥ 60 years, as well as completion of all laboratory testing and anthropometric measures. Individuals with inflammatory, rheumatic, auto-immune, chronic diseases, or use of medications that could modulate inflammatory markers were excluded. The local Ethics Committee for Human Research of Catholic University of Brasilia approved the methods of the present study, and all participants signed an informed consent document.</p>
<sec id="section3-0164027511415245">
<title>Anthropometric Measures</title>
<p>To better establish an anthropometric status, the following measures are performed: body mass index (BMI), waist and hip circumference, waist-to-hip ratio, body mass, and height. The normality values adopted for BMI, waist circumference, and waist-to-hip ratio (WHR) were those established by <xref ref-type="bibr" rid="bibr20-0164027511415245">Lipschitz (1994)</xref>, <xref ref-type="bibr" rid="bibr34-0164027511415245">WHO (2000)</xref>, and <xref ref-type="bibr" rid="bibr13-0164027511415245">Heyward and Wagner (2004)</xref>, respectively. Percentage body fat and fat-free mass were determined by dual-energy X-ray absorptiometry (DXA), and reference values were based on <xref ref-type="bibr" rid="bibr21-0164027511415245">Lohman (1992)</xref>.</p>
</sec>
<sec id="section4-0164027511415245">
<title>Metabolic Profile</title>
<p>The lipidogram was determined by an enzymatic method (Autohumalyzer, Human GMBH, Germany). Fasting glycemia was performed by ionic exchange technique with a colorimetric reaction. Glycosylated hemoglobin and basal insulinemia were measured by radioimmunoassay with the kits from Linco Research, Inc. (St Louis, Missouri, USA). The intra-assay coefficient of variation of the kits was 2.5% to 7.6% and 2.3% to 5.7%, respectively. The interassay coefficient of variation was 7.2% to 8.4% and 8.1% to 8.5%, respectively. The reference values adopted were those from the Executive Summary of the Third Report of the National Cholesterol Education Program (<xref ref-type="bibr" rid="bibr25-0164027511415245">NCEP Expert Panel, 2001</xref>), except for glycosylated hemoglobin and insulinemia. The normality percentage used for glycosylated hemoglobin was set at 6.5%, as recommended by the “<xref ref-type="bibr" rid="bibr1-0164027511415245">American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control” (2002)</xref>. IR was determined by the QUIKI index (Quantitative Insulin Sensitivity Check Index), with normal values being considered lower than 0.47, according to the descriptions of <xref ref-type="bibr" rid="bibr6-0164027511415245">Chen, Sullivan, and Quon (2005)</xref>.</p>
</sec>
<sec id="section5-0164027511415245">
<title>Inflammatory Parameters</title>
<p>The inflammatory parameters investigated were: CRP, IL-6, TNF-α, and interferon-gamma (INF-α). CRP was measured by the turbidimetric method with intensification by a particles reaction in the spectrophotometer Cobas Mira Plus (Roche Diagnostic), using a calibrator and control serum of Biosystem (Bayer). Cytokines were measured by Quantikine or Quantikine HS (High Sensitivity) commercial enzyme-linked immunosorbent assay Kits (R&amp;D Systems, Minneapolis, Minnesota, USA). The intra-assay coefficient of variation of the kits was 1.5% to 5.6% for IL-6 and 3.2% to 5.9% for INF-α. The interassay coefficient of variation was 4.3% to 6.4% for IL-6 and 3.1% to 6.5% for INF-α. The measures were performed in triplicate. To classify IL-6 values the procedures from <xref ref-type="bibr" rid="bibr12-0164027511415245">Harris et al. (1999)</xref> were adopted, where an elevated serum level was ≥ 2.08 pg/mL. This value was adopted because it was highly associated with a mortality rate of 50 by 1,000 per year in elderly individuals, corresponding to a 25th percentile of the group investigated in the present study. The same procedure was adopted for CRP with a value of 2.78 pg/mL (mortality rate for elderly of 63 by 1,000 per year according to <xref ref-type="bibr" rid="bibr12-0164027511415245">Harris et al., 1999</xref>), which also corresponds to a 25th percentile in our group. All the laboratory analyses were run with the same blood sample.</p>
<p>The reference adopted for TNF-α was that described by the manufacturer with normal values up to 4.12 pg/mL. INF-γ levels were presented as means and percentiles in order to compare this variable with the other inflammatory parameters and also with previous studies that evaluated this cytokine.</p>
</sec>
<sec id="section6-0164027511415245">
<title>Comparison Between Insulin Resistance and Noninsulin Resistance Elderly Women</title>
<p>To perform a comparative analysis of the anthropometric, metabolic, and inflammatory parameters, individuals were separated into two groups: the first composed of elderly women with insulin resistance (IR) and the second noninsulin resistance (NIR).</p>
<p>To identify the variables that exerted the most influence on insulin and fasting glucose levels, an analysis of regression was performed. The cutoff point used for glycemic values was 100 mg/dL, and for insulin the mean values between groups IR and NIR corresponded to 11 µU/mL.</p>
<p>The effect of glycemia on anthropometric, metabolic, and inflammatory parameters in the IR and NIR groups was checked by using the following subgroup division: Group 1 (IR &gt; 100 mg/dL), Group 2 (IR ≤ 100 mg/dL), Group 3 (NIR &gt; 100 mg/dL) and Group 4 (NIR ≤ 100 mg/dL).</p>
</sec>
<sec id="section7-0164027511415245">
<title>Statistical Analysis</title>
<p>Data were analyzed using the Statistical Package for Social Sciences Software (SPSS Version 19). The normality was checked by the Kolmogorov-Smirnov test. Results from anthropometric, metabolic, and inflammatory parameters are presented as percentages, quartiles, means, and standard deviations of the mean. Later, possible differences between groups were checked by student’s unpaired <italic>t</italic> test, and when subdivided by fasting glucose levels, a one-way analysis of variance (ANOVA) was used. The significance level adopted for all analyses was <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="section8-0164027511415245" sec-type="results">
<title>Results</title>
<p>The elderly women (<italic>N</italic> = 172) had a mean age of 67.5 (±5.4) years and presented an obesity profile. Specifically, individuals presented android obesity, elevated body fat, dyslipidemias, and hyperglycemia, characterized by the elevated mean values or close to the superior limit of normality, as well as by the percentile values of these parameters (<xref ref-type="table" rid="table1-0164027511415245">Table 1</xref>). Of the elderly women, 42.44% (<italic>n</italic> = 73) presented IR (<xref ref-type="table" rid="table1-0164027511415245">Table 1</xref>).</p>
<table-wrap id="table1-0164027511415245" position="float">
<label>Table 1.</label>
<caption><p>Anthropometric, Metabolic, and Inflammatory Parameters of the Subjects</p></caption>
<graphic alternate-form-of="table1-0164027511415245" xlink:href="10.1177_0164027511415245-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Minimum</th>
<th align="center">Maximum</th>
<th align="center"><italic>M</italic> ± <italic>SD</italic></th>
<th align="center">Percentile 25</th>
<th align="center">Percentile 50</th>
<th align="center">Percentile 75</th>
</tr>
</thead>
<tbody>
<tr>
<td>BMI (Kg/m<sup>2</sup>)</td>
<td>17.85</td>
<td>36.12</td>
<td>26.90 ± 40</td>
<td>24.80</td>
<td>26.90</td>
<td>30.40</td>
</tr>
<tr>
<td>WC (cm)</td>
<td>65.00</td>
<td>116.00</td>
<td>89.37 ± 10.86</td>
<td>82.13</td>
<td>90.00</td>
<td>96.75</td>
</tr>
<tr>
<td>WHC</td>
<td>0.69</td>
<td>1.07</td>
<td>0.89 ± 0.07</td>
<td>0.83</td>
<td>0.89</td>
<td>0.94</td>
</tr>
<tr>
<td>LBM (%)</td>
<td>18.30</td>
<td>52.90</td>
<td>37.38 ± 6.42</td>
<td>32.75</td>
<td>37.85</td>
<td>41.90</td>
</tr>
<tr>
<td>FM (%)</td>
<td>47.52</td>
<td>76.88</td>
<td>59.11 ± 5.98</td>
<td>54.61</td>
<td>58.12</td>
<td>63.26</td>
</tr>
<tr>
<td>TG (mg/dL)</td>
<td>48</td>
<td>320</td>
<td>151.33 ± 67.82</td>
<td>97.25</td>
<td>140.00</td>
<td>189.75</td>
</tr>
<tr>
<td>TL (mg/dL)</td>
<td>218</td>
<td>1.117</td>
<td>747.89 ± 139.04</td>
<td>656.00</td>
<td>749.00</td>
<td>832.75</td>
</tr>
<tr>
<td>TC (mg/dL)</td>
<td>126</td>
<td>343</td>
<td>233.15 ± 41.39</td>
<td>203.25</td>
<td>233.50</td>
<td>263.00</td>
</tr>
<tr>
<td>LDL-c (mg/dL)</td>
<td>43</td>
<td>250</td>
<td>140.77 ± 37.43</td>
<td>118.25</td>
<td>141.50</td>
<td>176.50</td>
</tr>
<tr>
<td>VLDL-c (mg/dL)</td>
<td>9</td>
<td>76</td>
<td>29.73 ± 13.40</td>
<td>19.00</td>
<td>28.00</td>
<td>37.00</td>
</tr>
<tr>
<td>HDL- (mg/dL)</td>
<td>32</td>
<td>92</td>
<td>60.82 ± 10.11</td>
<td>55.00</td>
<td>62.00</td>
<td>67.00</td>
</tr>
<tr>
<td>Glycated Hb (%)</td>
<td>4</td>
<td>8</td>
<td>5.6 ± 0.64</td>
<td>5.10</td>
<td>5.60</td>
<td>6.00</td>
</tr>
<tr>
<td>Glucose</td>
<td>60</td>
<td>528</td>
<td>102.64 ± 42.23</td>
<td>87.00</td>
<td>95.00</td>
<td>105.00</td>
</tr>
<tr>
<td>Insulin (µU/mL)</td>
<td>2.17</td>
<td>27.93</td>
<td>10.59 ± 5.60</td>
<td>5.77</td>
<td>8.94</td>
<td>12.43</td>
</tr>
<tr>
<td>CRP (pg/ml)</td>
<td>0.80</td>
<td>11.00</td>
<td>4.34 ± 0.15</td>
<td>2.86</td>
<td>4.24</td>
<td>5.2</td>
</tr>
<tr>
<td>IL-6 (pg/ml)</td>
<td>1.89</td>
<td>3.60</td>
<td>2.4 ± 0.02</td>
<td>2.08</td>
<td>2.34</td>
<td>2.73</td>
</tr>
<tr>
<td>TNF-α (pg/ml)</td>
<td>1.71</td>
<td>2.76</td>
<td>2.07 ± 0.00</td>
<td>1.95</td>
<td>2.07</td>
<td>2.16</td>
</tr>
<tr>
<td>INF-γ (pg/ml)</td>
<td>0.63</td>
<td>0.86</td>
<td>0.72 ± 0.04</td>
<td>0.69</td>
<td>0.71</td>
<td>0.75</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0164027511415245">
<p><italic>Note</italic>. BMI = body mass index; WC = waist circumference; WRH = by waist-to-hip ratio; LBM = lean body mass; FM = body fat percentage; TG = triglycerides; TL = total lipids; t-COL = total cholesterol; HDL = high density lipoprotein; LDL = low density lipoprotein; VLDL = very low density lipoprotein; Hg = hemoglobin; CRP = C reactive protein; IL-6 = interleukin-6; TNF-α = tumor necrosis factor-alpha; INF-γ = interferon-gamma.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Eighty percent of the elderly women exhibited levels above 0.8 pg/mL for CRP. From these, 25% presented very high levels of CRP, increasing the risk of mortality. IL-6 levels were elevated in 75% of the individuals, whereas TNF-α values were normal.</p>
<p>In those individuals with android obesity, insulin levels were higher (11.20 ± 5.87) as compared with those without android obesity (7.11 ± 3.55, <italic>p</italic> = 0.001). Body fat percentage was elevated in the elderly women, with only 19% (<italic>n</italic> = 33) presenting normal values The group with high insulin levels presented higher body mass index, waist circumference, waist-to-hip ratio, and body fat percentage, while lean body mass was lower compared with the group without insulin resistance (<xref ref-type="fig" rid="fig1-0164027511415245">Figure 1</xref>). There was no statistically significant difference in the blood inflammatory markers between IR and NIR groups (<xref ref-type="table" rid="table2-0164027511415245">Table 2</xref>).</p>
<fig id="fig1-0164027511415245" position="float">
<label>Figure 1.</label>
<caption><p>Anthropometric Parameters and Body Composition in Elderly Women With (IR) and Without Insulin Resistance (WIR)</p>
<p><italic>Note</italic>. BMI = body mass index; WC = waist circumference; WRH = by waist-to-hip ratio ; LBM = lean body mass; FM = body fat percentage.</p></caption>
<graphic xlink:href="10.1177_0164027511415245-fig1.tif"/>
</fig>
<table-wrap id="table2-0164027511415245" position="float">
<label>Table 2.</label>
<caption><p>Comparison of the Anthropometric, Metabolic, and Inflammatory Parameters Between IR and NIR Elderly Women</p></caption>
<graphic alternate-form-of="table2-0164027511415245" xlink:href="10.1177_0164027511415245-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">NIR (<italic>n</italic> = 99)</th>
<th align="center">IR (<italic>n</italic> = 73)</th>
<th align="center"><italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMI (Kg/m<sup>2</sup>)</td>
<td>25.84 ± 4.01</td>
<td>29.10 ± 3.27</td>
<td>0.001</td>
</tr>
<tr>
<td>WC (cm)</td>
<td>84.99 ± 10.5</td>
<td>95.32 ± 8.25</td>
<td>0.001</td>
</tr>
<tr>
<td>WHR</td>
<td>0.86 ± 0.75</td>
<td>0.92 ± 0.06</td>
<td>0.001</td>
</tr>
<tr>
<td>LBM (%)</td>
<td>60.71 ± 6.35</td>
<td>56.95 ± 4.67</td>
<td>0.001</td>
</tr>
<tr>
<td>FM (%)</td>
<td>35.49 ± 6.63</td>
<td>39.94 ± 5.17</td>
<td>0.001</td>
</tr>
<tr>
<td>TG (mg/dL)</td>
<td>134.25 ± 63.36</td>
<td>174.48 ± 67.20</td>
<td>0.001</td>
</tr>
<tr>
<td>TL (mg/dL)</td>
<td>731.73 ± 142.84</td>
<td>769.81 ± 131.50</td>
<td>0.07</td>
</tr>
<tr>
<td>t-COL (mg/dL)</td>
<td>234.37 ± 40.11</td>
<td>231.49 ± 43.30</td>
<td>0.65</td>
</tr>
<tr>
<td>HDL (mg/dL)</td>
<td>61.35 ± 9,53</td>
<td>60.42 ± 11.15</td>
<td>0.43</td>
</tr>
<tr>
<td>LDL (mg/dL)</td>
<td>144.99 ± 34.53</td>
<td>135.05 ± 40.59</td>
<td>0.08</td>
</tr>
<tr>
<td>VLDL (mg/dL)</td>
<td>26.57 ± 12.73</td>
<td>34.03 ± 13.17</td>
<td>0.001</td>
</tr>
<tr>
<td>Glycated Hg (%)</td>
<td>5.53 ± 0.57</td>
<td>5.7 ± 0.72</td>
<td>0.08</td>
</tr>
<tr>
<td>Glucose (mg/dL)</td>
<td>91.69 ± 12.29</td>
<td>118.08 ± 60.19</td>
<td>0.001</td>
</tr>
<tr>
<td>Insulin (µU/mL)</td>
<td>6.54 ± 2.23</td>
<td>15.01 ± 5.21</td>
<td>0.001</td>
</tr>
<tr>
<td>CRP (pg/ml)</td>
<td>4.15 ± 1.93</td>
<td>4.61 ± 2.20</td>
<td>0.15</td>
</tr>
<tr>
<td>IL-6 (pg/ml)</td>
<td>2.41 ± 0.41</td>
<td>2.43 ± 0.36</td>
<td>0.66</td>
</tr>
<tr>
<td>TNF-α (pg/ml)</td>
<td>2.6. ± 0.16</td>
<td>2.08 ± 0.12</td>
<td>0.44</td>
</tr>
<tr>
<td>INF-γ (pg/ml)</td>
<td>0.72 ± 0.04</td>
<td>0.72 ± 0.05</td>
<td>0.44</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0164027511415245">
<p><italic>Note</italic>. BMI = body mass index; WC = waist circumference; WRH = by waist-to-hip ratio; LBM = lean body mass; FM = body fat percentage; TG = triglycerides; TL = total lipids; t-COL = total cholesterol; HDL = high density lipoprotein; LDL = low density lipoprotein; VLDL = very low density lipoprotein; Hg = hemoglobin; CRP = C reactive protein; IL-6 = interleukin-6; TNF-α = tumor necrosis factor-alpha; INF-γ = interferon-gamma.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>VLDL and triglyceride levels were optimal in the NIR group, though they were elevated in the elderly women with IR (<xref ref-type="table" rid="table2-0164027511415245">Table 2</xref>, <xref ref-type="fig" rid="fig2-0164027511415245">Figure 2</xref>). IR women exhibited higher levels of triglycerides, hyperglycemia, and hyperinsulinemia (<xref ref-type="fig" rid="fig2-0164027511415245">Figure 2</xref>). Both groups presented normal values of glycated hemoglobin. There were no statistically significant difference between groups for total lipids, total cholesterol, HDL, LDL, and inflammatory parameters. Total cholesterol and LDL were above normal values for both groups, while total lipids and HDL were normal (<xref ref-type="table" rid="table2-0164027511415245">Table 2</xref>).</p>
<fig id="fig2-0164027511415245" position="float">
<label>Figure 2.</label>
<caption><p>Metabolic Parameters in Elderly Women With (IR) and Without Insulin Resistance (WIR)</p>
<p><italic>Note</italic>. TG = triglycerides; VLDL = very low density lipoprotein.</p></caption>
<graphic xlink:href="10.1177_0164027511415245-fig2.tif"/>
</fig>
</sec>
<sec id="section9-0164027511415245" sec-type="discussion">
<title>Discussion</title>
<p>The prevalence of individuals with type 2 diabetes, obesity, dyslipidemias, and cardiovascular disease has been increasing, especially in the countries under development where a demographic and nutritional transition is present, for example Brazil (<xref ref-type="bibr" rid="bibr24-0164027511415245">Monteiro, Mondini, Souza, &amp; Popkin, 1995</xref>; <xref ref-type="bibr" rid="bibr33-0164027511415245">WHO Consultation on Obesity, 1997</xref>). Elderly individuals with more than one co-morbidity may develop more health complications with a social and economic impact (<xref ref-type="bibr" rid="bibr33-0164027511415245">WHO Consultation on Obesity, 1997</xref>). In this sense, the results from the present study revealed that the elderly women presented an association of risk factors for cardiovascular disease involving anthropometric, metabolic, and inflammatory parameters. The initial hypothesis that elderly women with insulin resistance would present higher levels of inflammatory parameters than those without insulin resistance was not confirmed.</p>
<p>It is worth pointing out that the relationship between nutritional and inflammatory disturbances have been widely discussed in the literature, focusing on understanding possible mechanisms that may aid in the treatment and prevention of aging and the associated degenerative processes (<xref ref-type="bibr" rid="bibr28-0164027511415245">Sasaki et al., 2007</xref>; <xref ref-type="bibr" rid="bibr31-0164027511415245">Tracy et al., 1997</xref>). Insulin resistance is considered a potent predictor of type 2 diabetes (<xref ref-type="bibr" rid="bibr17-0164027511415245">Laaksonen et al., 2002</xref>). It has been shown that an obesity profile and excess of abdominal obesity is associated with increased risk of IR and inflammatory process (<xref ref-type="bibr" rid="bibr2-0164027511415245">Bergman et al., 2001</xref>; <xref ref-type="bibr" rid="bibr7-0164027511415245">Dandona, Aljada, Chaudhuri, Mohanty, &amp; Garg, 2005</xref>; <xref ref-type="bibr" rid="bibr15-0164027511415245">Kabir et al., 2005</xref>; <xref ref-type="bibr" rid="bibr35-0164027511415245">You, Yang, Lyles, Gong, &amp; Nicklas, 2005</xref>), as reported in the Results of the present study. The strong anti-lipolytic action of insulin may explain, at least in part, the elevation of free fat acids in IR individuals. In the present study, the IR elderly women presented elevated levels of triglycerides, fasting glycemia, and VLDL, as previously reported (<xref ref-type="bibr" rid="bibr27-0164027511415245">Pankow, Jacobs, Steinberger, Moran, &amp; Sinaiko, 2004</xref>). Although not controlled in the present study, it is obvious that inadequate dietary behaviors can modify nutritional status and increase the risk of developing dyslipidemias.</p>
<p>There was an association between the hyperinsulinemia observed in IR elderly women with the anthropometric parameters. Considering BMI values, obese women had higher insulin levels than eutrophic and underweight women. It has been shown that excess body weight, elevated waist circumference, and BMI are efficient predictors of cardiovascular dysfunctions (<xref ref-type="bibr" rid="bibr14-0164027511415245">Janssen et al., 2004</xref>). The results from the present study highlight that elevated insulin levels associated with anthropometric variables can be used as predictors of cardiovascular disease.</p>
<p>The association between anthropometric, metabolic, and inflammatory parameters with elevated glycemia, independently of IR, reinforces the importance of the effects of glucose monitoring on these parameters. Similarly, another study revealed that independently of IR, elevated glycemia is present in elderly women with lipemic, anthropometric, and body fat disturbances (<xref ref-type="bibr" rid="bibr23-0164027511415245">Mokdad et al., 2003</xref>).</p>
<p>The present study proposes that elderly NIR women with elevated glycemia levels should be monitored for possible cardiovascular risk. In fact, studies have been showing that elevated waist-hip ratio and waist circumference are strongly associated with cardiovascular disease (<xref ref-type="bibr" rid="bibr3-0164027511415245">Bulló, García-Lorda, Megias, &amp; Salas-Salvadó, 2003</xref>; <xref ref-type="bibr" rid="bibr4-0164027511415245">Cabrera et al., 2007</xref>; <xref ref-type="bibr" rid="bibr16-0164027511415245">Kannel, Wilson, Nam, &amp; D’Agostino, 2002</xref>; <xref ref-type="bibr" rid="bibr30-0164027511415245">Tonstad &amp; Hjermann, 2003</xref>). Elderly women presented an inflammatory profile associated with obesity, dyslipidemia, and glycemic disturbance. Most elderly women exhibited elevated IL-6 levels, with mean values compatible to those found by <xref ref-type="bibr" rid="bibr12-0164027511415245">Harris et al. (1999)</xref> for a mortality rate of 50 per 1,000 each year. Similarly, RCP was also elevated and highlighted the risk of mortality at a rate of 63 per 1,000 each year. It is interesting to observe that the inflammatory profile of this group of Brazilian elderly was similar to that found in American elderly (<xref ref-type="bibr" rid="bibr12-0164027511415245">Harris et al., 1999</xref>).</p>
<p>Both IL-6 and CRP levels are commonly elevated in obese individuals, considering that ~30% of IL-6 is produced in the adipose tissue and that this cytokine regulates the synthesis of CRP by the liver (<xref ref-type="bibr" rid="bibr19-0164027511415245">Lemieux et al., 2001</xref>; <xref ref-type="bibr" rid="bibr32-0164027511415245">Trayhurn &amp; Wood, 2004</xref>) TNF-α is also considered an obesity-associated inflammatory marker, as this cytokine is also produced in adipose cells. However, in the present study, serum levels of TNF-α were within a normal range, which is compatible with the finding that high levels of TNF-α expression in adipose tissue are not associated with a significant increase in serum levels of this cytokine (<xref ref-type="bibr" rid="bibr36-0164027511415245">Xu et al., 2003</xref>).</p>
<p>The knowledge of a link between obesity, IR, and inflammatory process motivated the investigation of serum cytokine levels in IR and NIR elderly women. There is an association between IR and serum levels of CRP, IL-6, and TNF-α. However, mean values of these cytokines were not statistically different between IR and NIR women. A possible explanation for this lack of difference is the fact that both groups presented obesity characteristics, especially android obesity, although IR women exhibited higher values.</p>
<p>The results of the present study failed to reveal an association between the inflammatory parameters and IR, possibly because all women already had elevated inflammatory, anthropometric, and lipemic values, whereas IR elderly, in general, exhibited superior anthropometric and metabolic disturbances. Is summary, resting glycemic values should be carefully monitored in order to prevent cardiovascular and metabolic disease, independently of IR. Additional systemic inflammatory parameters should be used to aid in IR determination in clinical practice. Anthropometric and metabolic profiles should be considered to determine IR and inflammation state.</p>
</sec>
</body>
<back>
<ack>
<p>We are very grateful for the English revision performed by Scott Lyons, PhD. This study is part of a partnership between the Graduation Program in Gerontology and the Graduation Program in Physical Education and Health. From this partnership, there are several other studies being conducted with elderly individuals. We have several health care professionals involved with multiple scientific interests.</p>
</ack>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0164027511415245">
<citation citation-type="journal">
<collab>American College of Endocrinology consensus statement on guidelines for glycemic control</collab>. (<year>2002</year>). <source>Endocrine Practice</source>, <volume>8</volume>(<issue>S1</issue>), <fpage>6</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr2-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bergman</surname><given-names>R. N.</given-names></name>
<name><surname>Van Citters</surname><given-names>G. W.</given-names></name>
<name><surname>Mittelman</surname><given-names>S. D.</given-names></name>
<name><surname>Dea</surname><given-names>M. K.</given-names></name>
<name><surname>Hamilton-Wessler</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>S. P.</given-names></name>
<name><surname>Ellmerer</surname><given-names>M.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Central role of the adipocyte in the metabolic syndrome</article-title>. <source>Journal of Investigative Medicine</source>, <volume>49</volume>, <fpage>119</fpage>-<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr3-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bulló</surname><given-names>M.</given-names></name>
<name><surname>García-Lorda</surname><given-names>P.</given-names></name>
<name><surname>Megias</surname><given-names>I.</given-names></name>
<name><surname>Salas-Salvadó</surname><given-names>J.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Systemic inflammation, adipose tissue, tumor necrosis factor, and leptin expression</article-title>. <source>Obesity Research</source>, <volume>11</volume>(<issue>4</issue>), <fpage>525</fpage>-<lpage>531</lpage>.</citation>
</ref>
<ref id="bibr4-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cabrera</surname><given-names>M. A. S.</given-names></name>
<name><surname>Gebara</surname><given-names>O. C. E.</given-names></name>
<name><surname>Diament</surname><given-names>J.</given-names></name>
<name><surname>Nussbacher</surname><given-names>A.</given-names></name>
<name><surname>Rosano</surname><given-names>G.</given-names></name>
<name><surname>Wajngarten</surname><given-names>M.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women</article-title>. <source>International Journal of Cardiology</source>, <volume>114</volume>(<issue>2</issue>), <fpage>224</fpage>-<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr5-0164027511415245">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Camarano</surname><given-names>A. A.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Características das instituições de longa permanência para idosos–Região Norte</article-title> [<trans-title xml:lang="en">Characteristics of long stay institutions for elderly-North Region</trans-title>]. <publisher-loc>Brasilia</publisher-loc>: <publisher-name>IPEA; Presidência da República</publisher-name>.</citation>
</ref>
<ref id="bibr6-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Sullivan</surname><given-names>G.</given-names></name>
<name><surname>Quon</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model</article-title>. <source>Diabetes</source>, <volume>54</volume>, <fpage>1914</fpage>-<lpage>1925</lpage>.</citation>
</ref>
<ref id="bibr7-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dandona</surname><given-names>P.</given-names></name>
<name><surname>Aljada</surname><given-names>A.</given-names></name>
<name><surname>Chaudhuri</surname><given-names>A.</given-names></name>
<name><surname>Mohanty</surname><given-names>P.</given-names></name>
<name><surname>Garg</surname><given-names>R.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation</article-title>. <source>Circulation</source>, <volume>111</volume>, <fpage>1448</fpage>-<lpage>1454</lpage>.</citation>
</ref>
<ref id="bibr8-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fonseca-Alaniz</surname><given-names>M. H.</given-names></name>
<name><surname>Takada</surname><given-names>J.</given-names></name>
<name><surname>Alonse-Vale</surname><given-names>M. I. C.</given-names></name>
<name><surname>Lima</surname><given-names>F. B.</given-names></name>
</person-group> (<year>2006</year>). <article-title>The adipose tissue as regulatory center of the metabolism</article-title>. <source>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</source>, <volume>50</volume>, <fpage>216</fpage>-<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr9-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ford</surname><given-names>E. S.</given-names></name>
</person-group> (<year>1999</year>). <article-title>Body mass index, diabetes, and C-protein among U.S. adults</article-title>. <source>Diabetes Care</source>, <volume>22</volume>, <fpage>1971</fpage>-<lpage>1977</lpage>.</citation>
</ref>
<ref id="bibr10-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Forsey</surname><given-names>R. J.</given-names></name>
<name><surname>Thompson</surname><given-names>J. M.</given-names></name>
<name><surname>Ernerudh</surname><given-names>J.</given-names></name>
<name><surname>Hurst</surname><given-names>T. L.</given-names></name>
<name><surname>Strindhall</surname><given-names>J.</given-names></name>
<name><surname>Johansson</surname><given-names>B.</given-names></name>
<name><surname>Nilsson</surname><given-names>B.-O.</given-names></name>
<name><surname>Wikby</surname><given-names>A.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Plasma cytokine profiles in elderly humans</article-title>. <source>Mechanisms of Ageing and Development</source>, <volume>124</volume>, <fpage>487</fpage>-<lpage>493</lpage>.</citation>
</ref>
<ref id="bibr11-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franceschi</surname><given-names>C.</given-names></name>
<name><surname>Bonafè</surname><given-names>M.</given-names></name>
<name><surname>Valensin</surname><given-names>S.</given-names></name>
<name><surname>Olivieri</surname><given-names>F.</given-names></name>
<name><surname>De Luca</surname><given-names>M.</given-names></name>
<name><surname>Ottaviani</surname><given-names>E.</given-names></name>
<name><surname>De Benedictis</surname><given-names>G.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Inflammaging. An evolutionary perspective on immunosenescence</article-title>. <source>Annals: The New York Academy of Sciences</source>, <volume>908</volume>, <fpage>244</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr12-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>T. B.</given-names></name>
<name><surname>Ferrucci</surname><given-names>L.</given-names></name>
<name><surname>Tracy</surname><given-names>R. P.</given-names></name>
<name><surname>Corti</surname><given-names>M. C.</given-names></name>
<name><surname>Wacholder</surname><given-names>S.</given-names></name>
<name><surname>Ettinger</surname><given-names>W. H.</given-names></name>
<name><surname>Heimovitz</surname><given-names>H.</given-names></name>
<name><surname>Cohen</surname><given-names>H. J.</given-names></name>
<name><surname>Wallacel</surname><given-names>R.</given-names></name>
</person-group> (<year>1999</year>). <article-title>Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly</article-title>. <source>American Journal of Medicine</source>, <volume>106</volume>, <fpage>506</fpage>-<lpage>512</lpage>.</citation>
</ref>
<ref id="bibr13-0164027511415245">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Heyward</surname><given-names>V. H.</given-names></name>
<name><surname>Wagner</surname><given-names>D.</given-names></name>
</person-group> (<year>2004</year>). <source>Applied body composition assessment</source>. <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>Human Kinetics</publisher-name>.</citation>
</ref>
<ref id="bibr14-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Janssen</surname><given-names>I.</given-names></name>
<name><surname>Katzmarzyk</surname><given-names>P. T</given-names></name>
<name><surname>Ross</surname><given-names>R.</given-names></name>
<name><surname>Leon</surname><given-names>A. S.</given-names></name>
<name><surname>Skinner</surname><given-names>J. S.</given-names></name>
<name><surname>Rao</surname><given-names>D. C</given-names></name>
<name><surname>Wilmore</surname><given-names>J. H.</given-names></name>
<name><surname>Rankinen</surname><given-names>T.</given-names></name>
<name><surname>Bouchard</surname><given-names>C.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Fitness alters the associations of BMI and waist circumference with total and abdominal fat</article-title>. <source>Obesity Research</source>, <volume>12</volume>, <fpage>525</fpage>-<lpage>537</lpage>.</citation>
</ref>
<ref id="bibr15-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kabir</surname><given-names>M.</given-names></name>
<name><surname>Catalano</surname><given-names>K. J.</given-names></name>
<name><surname>Ananthnarayan</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>S. P.</given-names></name>
<name><surname>Van Citters</surname><given-names>G.</given-names></name>
<name><surname>Dea</surname><given-names>M. K.</given-names></name>
<name><surname>Bergman</surname><given-names>R. N.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Molecular evidence supporting the portal theory: A causative link between visceral adiposity and hepatic insulin resistance</article-title>. <source>American Journal of Physiology: Endocrinology and Metabolism</source>, <volume>288</volume>, <fpage>E454</fpage>-<lpage>E461</lpage>.</citation>
</ref>
<ref id="bibr16-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kannel</surname><given-names>W. B.</given-names></name>
<name><surname>Wilson</surname><given-names>P. W. F.</given-names></name>
<name><surname>Nam</surname><given-names>B.-H.</given-names></name>
<name><surname>D’Agostino</surname><given-names>R. B.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Risk stratification of obesity as a coronary risk factor</article-title>. <source>American Journal of Cardiology</source>, <volume>90</volume>, <fpage>697</fpage>-<lpage>701</lpage>.</citation>
</ref>
<ref id="bibr17-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Laaksonen</surname><given-names>D. E.</given-names></name>
<name><surname>Lakka</surname><given-names>H.-M.</given-names></name>
<name><surname>Niskanen</surname><given-names>L. K.</given-names></name>
<name><surname>Kaplan</surname><given-names>G. A.</given-names></name>
<name><surname>Salonen</surname><given-names>J. T.</given-names></name>
<name><surname>Lakka</surname><given-names>T. A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study</article-title>. <source>American Journal of Epidemiology</source>, <volume>156</volume>, <fpage>1070</fpage>-<lpage>1077</lpage>.</citation>
</ref>
<ref id="bibr18-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lakka</surname><given-names>T.</given-names></name>
<name><surname>Lakka</surname><given-names>H.-M.</given-names></name>
<name><surname>Salonen</surname><given-names>R.</given-names></name>
<name><surname>Kaplan</surname><given-names>G. A.</given-names></name>
<name><surname>Salonen</surname><given-names>J. T.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men</article-title>. <source>Atherosclerosis</source>, <volume>154</volume>, <fpage>497</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr19-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lemieux</surname><given-names>I.</given-names></name>
<name><surname>Pascot</surname><given-names>A.</given-names></name>
<name><surname>Prud’homme</surname><given-names>D.</given-names></name>
<name><surname>Alméras</surname><given-names>N.</given-names></name>
<name><surname>Bogaty</surname><given-names>P.</given-names></name>
<name><surname>Nadeau</surname><given-names>A.</given-names></name>
<name><surname>Bergeron</surname><given-names>J.</given-names></name>
<name><surname>Després</surname><given-names>J.-P.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Elevated C-reactive protein</article-title>. <source>Another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology</source>, <volume>21</volume>(<issue>6</issue>), <fpage>961</fpage>-<lpage>967</lpage>.</citation>
</ref>
<ref id="bibr20-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lipschitz</surname><given-names>D. A.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Screening for nutritional status in the elderly</article-title>. <source>Primary Care</source>, <volume>21</volume>, <fpage>55</fpage>-<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr21-0164027511415245">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lohman</surname><given-names>T. G.</given-names></name>
</person-group> (<year>1992</year>). <source>Advances in body composition assessment</source>. <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>Human Kinetics Publishers</publisher-name>.</citation>
</ref>
<ref id="bibr22-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLellan</surname><given-names>K. C. P.</given-names></name>
<name><surname>Barbalho</surname><given-names>S. M.</given-names></name>
<name><surname>Cattalini</surname><given-names>M.</given-names></name>
<name><surname>Lerario</surname><given-names>A. C.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Type 2 diabetes mellitus, metabolic syndrome and change in lifestyle</article-title>. <source>Revista de Nutrição</source>, <volume>20</volume>, <fpage>515</fpage>-<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr23-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mokdad</surname><given-names>A. H.</given-names></name>
<name><surname>Ford</surname><given-names>E. S.</given-names></name>
<name><surname>Bowman</surname><given-names>B. A.</given-names></name>
<name><surname>Dietz</surname><given-names>W. H.</given-names></name>
<name><surname>Vinicor</surname><given-names>F.</given-names></name>
<name><surname>Bales</surname><given-names>V. S.</given-names></name>
<name><surname>Marks</surname><given-names>J. S.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Prevalence of obesity, diabetes, and obesity-related health risk factors</article-title>. <source>Journal of the American Medical Association</source>, <volume>289</volume>, <fpage>76</fpage>-<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr24-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Monteiro</surname><given-names>C. A.</given-names></name>
<name><surname>Mondini</surname><given-names>L.</given-names></name>
<name><surname>Souza</surname><given-names>A. L.</given-names></name>
<name><surname>Popkin</surname><given-names>B. M.</given-names></name>
</person-group> (<year>1995</year>). <article-title>The nutrition transition in Brazil</article-title>. <source>European Journal of Clinical Nutrition</source>, <volume>49</volume>, <fpage>105</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr25-0164027511415245">
<citation citation-type="journal">
<collab>NCEP Expert Panel</collab>. (<year>2001</year>). <article-title>Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)</article-title>. <source>Journal of the American Medical Association</source>, <volume>285</volume>, <fpage>2486</fpage>-<lpage>2497</lpage>.</citation>
</ref>
<ref id="bibr26-0164027511415245">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>L. A. P.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Síntese de indicadores sociais - uma análise das condições de vida da população brasileira</article-title> [<trans-title xml:lang="en">Synthesis of social indicators - an analysis of the life conditions of Brazilian population</trans-title>]. (pp. <fpage>1</fpage>-<lpage>280</lpage>). <publisher-loc>Rio de Janeiro</publisher-loc>: <publisher-name>IBGE 280</publisher-name>.</citation>
</ref>
<ref id="bibr27-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pankow</surname><given-names>J. S.</given-names></name>
<name><surname>Jacobs</surname><given-names>D. R.</given-names></name>
<name><surname>Steinberger</surname><given-names>J.</given-names></name>
<name><surname>Moran</surname><given-names>A.</given-names></name>
<name><surname>Sinaiko</surname><given-names>A. R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome</article-title>. <source>Diabetes Care</source>, <volume>27</volume>, <fpage>775</fpage>-<lpage>780</lpage>.</citation>
</ref>
<ref id="bibr28-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sasaki</surname><given-names>J. E.</given-names></name>
<name><surname>Krause</surname><given-names>M. P.</given-names></name>
<name><surname>Gama</surname><given-names>M. P. R.</given-names></name>
<name><surname>Hallage</surname><given-names>T.</given-names></name>
<name><surname>Buzzachera</surname><given-names>C. F.</given-names></name>
<name><surname>Santos</surname><given-names>M. G.</given-names></name>
<name><surname>Da Silva</surname><given-names>S. G.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Influence of overall and abdominal adiposity on C-reactive protein levels in elderly women</article-title>. <source>Arquivos Brasileiros de Cardiologia</source>, <volume>89</volume>, <fpage>231</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr29-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stephens</surname><given-names>J. W.</given-names></name>
<name><surname>Ambler</surname><given-names>G.</given-names></name>
<name><surname>Vallence</surname><given-names>P.</given-names></name>
<name><surname>Betteridge</surname><given-names>D. J.</given-names></name>
<name><surname>Humphries</surname><given-names>S. E.</given-names></name>
<name><surname>Hurel</surname><given-names>S. J.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Cardiovascular risk and diabetes</article-title>. <source>Are the methods of risk prediction satisfactory? European Journal of Cardiovascular Prevention and Rehabilitation</source>, <volume>11</volume>, <fpage>521</fpage>-<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr30-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tonstad</surname><given-names>S.</given-names></name>
<name><surname>Hjermann</surname><given-names>I.</given-names></name>
</person-group> (<year>2003</year>). <article-title>A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women</article-title>. <source>Journal of Cardiovascular Risk</source>, <volume>10</volume>, <fpage>129</fpage>-<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr31-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tracy</surname><given-names>R. P.</given-names></name>
<name><surname>Lemaitre</surname><given-names>R. N.</given-names></name>
<name><surname>Psaty</surname><given-names>B. M.</given-names></name>
<name><surname>Ives</surname><given-names>D. G.</given-names></name>
<name><surname>Evans</surname><given-names>R. W.</given-names></name>
<name><surname>Cushman</surname><given-names>M.</given-names></name>
<name><surname>Meilahn</surname><given-names>E. N.</given-names></name>
<name><surname>Kuller</surname><given-names>L. H.</given-names></name>
</person-group> (<year>1997</year>). <article-title>Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project</article-title>. <source>Arteriosclerosis, Thrombosis, and Vascular Biology</source>, <volume>17</volume>, <fpage>1121</fpage>-<lpage>1127</lpage>.</citation>
</ref>
<ref id="bibr32-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trayhurn</surname><given-names>P. E.</given-names></name>
<name><surname>Wood</surname><given-names>S. I.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Adipokines: Inflammation and the pleiotropic role of white adipose tissue</article-title>. <source>British Journal of Nutrition</source>, <volume>92</volume>(<issue>3</issue>), <fpage>347</fpage>-<lpage>355</lpage>.</citation>
</ref>
<ref id="bibr33-0164027511415245">
<citation citation-type="book">
<collab>World Health Organization (WHO) Consultation on Obesity</collab>. (<year>1997</year>). <source>Obesity: Prevention and managing: The global epidemic</source> (<comment>Report of a WHO Consultation on Obesity</comment>). <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>Author</publisher-name>.</citation>
</ref>
<ref id="bibr34-0164027511415245">
<citation citation-type="book">
<collab>World Health Organization (WHO)</collab>. (<year>2000</year>). <source>Obesity: Preventing and managing the global epidemic</source> (<comment>WHO Technical Report Series 894</comment>). <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>Author</publisher-name>.</citation>
</ref>
<ref id="bibr35-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>You</surname><given-names>T.</given-names></name>
<name><surname>Yang</surname><given-names>R.</given-names></name>
<name><surname>Lyles</surname><given-names>M. F.</given-names></name>
<name><surname>Gong</surname><given-names>D.</given-names></name>
<name><surname>Nicklas</surname><given-names>B. J.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Abdominal adipose tissue cytokine gene expression: Relationship to obesity and metabolic risk factors</article-title>. <source>American Journal of Physiology: Endocrinology and Metabolism</source>, <volume>288</volume>, <fpage>E741</fpage>-<lpage>E747</lpage>.</citation>
</ref>
<ref id="bibr36-0164027511415245">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Barnes</surname><given-names>G. T.</given-names></name>
<name><surname>Guo</surname><given-names>Q. Y.</given-names></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<name><surname>Chou</surname><given-names>C. J.</given-names></name>
<name><surname>Sole</surname><given-names>J.</given-names></name>
<name><surname>Nichols</surname><given-names>A.</given-names></name>
<name><surname>Ross</surname><given-names>J. S.</given-names></name>
<name><surname>Tartaglia</surname><given-names>L. A.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance</article-title>. <source>Journal of Clinical Investigation</source>, <volume>112</volume>(<issue>12</issue>), <fpage>1821</fpage>-<lpage>1830</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>